Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customers
5. United Kingdom Prostate Cancer Therapeutics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Treatment (Hormonal Therapy, Immunotherapy, Targeted Therapy, Chemotherapy, Others)
5.2.2. By End User (Hospital pharmacies, Retail pharmacies, Online pharmacies)
5.2.3. By Company (2022)
5.2.4. By Region
5.3. Market Map
5.3.1. By Treatment
5.3.2. By End User
5.3.3. By Region
6. United Kingdom Prostate Cancer Hormonal Therapy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists, Luteinizing Hormone-Releasing Hormone (LHRH) Agonists, Anti-Androgen)
6.2.2. By End User
7. United Kingdom Prostate Cancer Chemotherapy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Taxotere, Jevtana)
7.2.2. By End User
8. United Kingdom Prostate Cancer Immunotherapy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By End User
9. United Kingdom Prostate Cancer Targeted Therapy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By End User
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Mergers & Acquisitions
11.2. Recent Trends & Developments
11.3. New Type Launches
12. United Kingdom Prostate Cancer Therapeutics Market: SWOT Analysis
13. Porters Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Types
14. PESTLE Analysis
15. Policy & Regulatory Landscape
16. United Kingdom Economic Profile
17. Competitive Landscape
17.1. Johnson & Johnson
17.2. Astellas Pharma Inc
17.3. Ipsen Pharma
17.4. Sanofi
17.5. Bayer AG
17.6. AstraZeneca
17.7. Pfizer Inc.
17.8. Teva Pharmaceutical Industries Ltd.
17.9. Abbott
17.10. GlaxoSmithKline plc
18. Strategic Recommendations
About us & Disclaimer